Results 201 to 210 of about 37,259 (377)
Dissolvable Immunomodulatory Microneedles for Treatment of Skin Wounds [PDF]
Pejman Ghelich +16 more
openalex +1 more source
Analysis of Trend of Studies on Microneedle Treatment System (MTS)
Hea-Sun Chun, Ho-Seub Song
openalex +2 more sources
Implantable Drug Delivery Systems for Skeletal Muscles and Eyes
This review highlights the different types of recent implantable drug delivery systems (IDDS) fabricated for a use with skeletal muscles, and with eyes. It presents the developments already made and the current research directions, showing the evolution of IDDS and their great diversity.
Serge Ostrovidov +8 more
wiley +1 more source
Transdermal microneedles for insulin delivery [PDF]
Cristiane Patricia Pissinato Pere
openalex
Micro/Nanorobot for Drug Delivery—A Review of Material Selections
This review explores material strategies for biomedical micro/nanorobots, emphasizing their roles in propulsion, navigation, drug delivery, and biodegradability. It highlights advancements in metallic, polymeric, and hybrid materials, while addressing clinical translation challenges such as toxicity, immune response, and manufacturability.
Xiaozhuo Wu, Bingyun Li, Malcolm Xing
wiley +1 more source
Rapid paper based colorimetric detection of glucose using a hollow microneedle device
Dean Nicholas +8 more
openalex +2 more sources
Nanomedicines and microneedles: a guide to their analysis and application
Rachel E. Sully +5 more
openalex +2 more sources
Advances and Challenges in Micro/Nanocarrier‐Based Dermal Drug Delivery Systems for Acne Treatment
Topical acne treatment faces challenges from skin barriers and complex causes. Micro/nanocarriers improve drug delivery by enhancing bioavailability, targeting, and duration. Combining carriers creates synergistic effects for systematic intervention.
Jintao Yang +7 more
wiley +1 more source
Advances in microneedle-based therapy for bone disorders
Zengping Lin +3 more
openalex +1 more source
This review highlights how autoimmune diseases arise from intertwined immunological, genetic, and environmental factors, emphasizing gut microbiota dysbiosis as a pivotal driver. It outlines emerging nanotechnology‐based strategies—such as liposomes, hydrogels, and polymeric nanoparticles—that enhance targeted drug delivery, minimize systemic toxicity,
Md. Meraj Ansari +5 more
wiley +1 more source

